These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8114269)

  • 21. [In vitro susceptibilites to levofloxacin and various antibacterial agents of 11,475 clinical isolates obtained from 52 centers in 2002].
    Yamaguchi K; Ohno A; Kashitani F; Iwata M; Kanda M; Tsujio Y; Shimoyama N; Okujima H; Ito M; Kawaguchi H; Chiba H; Akizawa K; Katayama Y; Sugimoto K; Tashiro H; Kaimori M; Suwabe A; Obata R; Sugiyama T; Toyoshima S; Kato J; Kaku M; Kanemitsu K; Kunishima H; Okada J; Tazawa Y; Igari J; Oguri T; Watanabe K; Kobayashi Y; Uchida H; Totsuka K; Kon S; Nakamura K; Matsuda K; Hayashi I; Shiotani J; Shiotani J; Kanno H; Itoh A; Sumitomo M; Uchida T; Kawabata A; Oiwa C; Iwata M; Horii T; Ishigo S; Yoshimura T; Ichiyama S; Wada Y; Kimura S; Maesaki S; Itoh K; Noda Y; Yamashita T; Yamaguchi I; Kageyama F; Shaku E; Baba H; Inuzuka K; Okabe H; Tatewaki K; Moro K; Aihara M; Matsushima T; Niki Y; Kuw Abara M; Ikawa S; Tanaka M; Hinoda Y; Sugiura T; Kamioka M; Ono J; Takata T; Makino H; Murase M; Miyamoto H; Aizawa H; Honda J; Takii M; Nagasawa Z; Aoki Y; Hamazaki N; Tsutsui T; Nakagawa K; Iwata M; Hiramatsu K; Saikawa T; Yamane N; Kimoto H; Kotani T; Kageoka T; Hongo T; Masuda J; Miyanohara H; Tsujimura M; Yasujima M; Hayashi I
    Jpn J Antibiot; 2005 Feb; 58(1):17-44. PubMed ID: 15849869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antimicrobial activities of sulbactam/ampicillin against clinically isolated microbial strains].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1995 Apr; 48(4):529-47. PubMed ID: 7783316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1991)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kondou T; Kobayashi K; Satou K; Matsumiya H; Saito A
    Jpn J Antibiot; 1995 Aug; 48(8):965-98. PubMed ID: 7474326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ceftaroline activity tested against bacterial isolates from pediatric patients: results from the assessing worldwide antimicrobial resistance and evaluation program for the United States (2011-2012).
    Sader HS; Mendes RE; Farrell DJ; Flamm RK; Jones RN
    Pediatr Infect Dis J; 2014 Aug; 33(8):837-42. PubMed ID: 25222304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Fujime M; Fujita K; Shigeta S; Watanabe J; Igari J; Ogiwara M; Ishibashi K; Oguri T; Yoshida H; Imafuku Y; Yamaguchi K; Matsumoto T; Kashitani F; Murai M; Ooe H; Nishikawa M; Watanabe K; Kobayashi Y; Uchida H; Oka T; Mochida C
    Jpn J Antibiot; 1999 Feb; 52(2):93-129. PubMed ID: 10221177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiological and antibiotic resistant study on extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Zhejiang Province.
    Yu Y; Zhou W; Chen Y; Ding Y; Ma Y
    Chin Med J (Engl); 2002 Oct; 115(10):1479-82. PubMed ID: 12490091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Cha R
    Pharmacotherapy; 2008 Mar; 28(3):295-300. PubMed ID: 18294108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of minocycline and cefuzonam for antimicrobial activity against clinical isolates.
    Igari J; Oguri T; Higuchi T
    Jpn J Antibiot; 1994 Aug; 47(8):1013-29. PubMed ID: 7933531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1995 Sep; 48(9):1131-60. PubMed ID: 7474333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro antibacterial activities of ticarcillin alone and ticarcillin plus clavulanic acid against beta-lactamase producing and non-producing microorganisms.
    Hsueh PR; Chang SC; Chen YC; Hsu LY; Luh KT; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Aug; 25(3):149-59. PubMed ID: 1342000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibacterial susceptibility of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Bishara J; Livne G; Ashkenazi S; Levy I; Pitlik S; Ofir O; Lev B; Samra Z
    Isr Med Assoc J; 2005 May; 7(5):298-301. PubMed ID: 15909461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial susceptibility of extended-spectrum beta-lactamase producers and multidrug-resistant Acinetobacter baumannii throughout the United States and comparative in vitro activity of tigecycline, a new glycylcycline antimicrobial.
    Hoban DJ; Bouchillon SK; Dowzicky MJ
    Diagn Microbiol Infect Dis; 2007 Apr; 57(4):423-8. PubMed ID: 17403448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.
    Liu HY; Lin HC; Lin YC; Yu SH; Wu WH; Lee YJ
    J Microbiol Immunol Infect; 2011 Oct; 44(5):364-8. PubMed ID: 21524974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vitro bactericidal activities of new oral penem, faropenem against the various clinical isolates].
    Matsuzaki K; Nishiyama T; Hasegawa M; Kobayashi I; Kaneko A; Sasaki J
    Jpn J Antibiot; 1999 May; 52(5):431-8. PubMed ID: 10480050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2001)].
    Shimada K; Oguri T; Igari J; Ikemoto H; Mori T; Kitamura N; Nakano K; Suzuki Y; Yokouchi H; Karasawa Y; Terai T; Yamamoto M; Nakata K; Nakatani T; Inoue H; Nakadate T; Inagawa H; Suwabe A; Obata R; Kudo K; Kobayashi N; Ohno I; Okada S; Hayashi K; Kinoshita T; Konosaki H; Arakawa M; Gejyo F; Kobayashi H; Goto H; Igarashi K; Kawai S; Okada M; Ito A; Sumitomo M; Aoki N; Matsushima T; Niki Y; Suga M; Hirakata Y; Aoki S; Matsuda J; Tosaka M; Nasu M; Nagai H; Kohno S; Tomono K; Miyazaki Y; Hiramatsu K; Nakano T
    Jpn J Antibiot; 2003 Oct; 56(5):365-95. PubMed ID: 14692377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Susceptibility of bacteria isolated from lower respiratory tract infections to antibiotics (1983)].
    Ikemoto H; Watanabe K; Kosakai N; Hayashi Y; Oguri T; Saito A; Shinohara M; Matsumiya H; Ueda K; Ida S
    Jpn J Antibiot; 1985 Nov; 38(11):3119-44. PubMed ID: 3937915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
    Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibacterial agents (2010)].
    Goto H; Iwasaki M
    Jpn J Antibiot; 2015 Apr; 68(2):85-104. PubMed ID: 26182813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1999)].
    Shimada K; Nakano K; Ohno I; Okada S; Hayashi K; Yokouchi H; Arakawa M; Gejyo F; Igarashi K; Ikemoto H; Mori T; Okada M; Ozaki K; Igari J; Aoki N; Oguri T; Kitamura N; Terai T; Suzuki Y; Inoue H; Nakadate T; Karasawa Y; Ito C; Yoshida T; Nakata K; Nakatani T; Inagawa H; Ando M; Suga M; Sato K; Kudo K; Kobayashi N; Tosaka M; Hasegawa M; Kohno S; Tomono K; Miyazaki Y; Kobayashi H; Kawai S; Takayasu S; Hirakata Y; Matsuda J; Mochida C; Ito A; Sumitomo M; Nasu M; Nagai H; Matsushima T; Niki Y; Hiramatsu K; Nakano T
    Jpn J Antibiot; 2001 Jul; 54(7):331-64. PubMed ID: 11560054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibacterial activities of amoxicillin alone and in combination with clavulanic acid correlated with beta-lactamase production.
    Hsu LY; Chang SC; Luh KT; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Aug; 24(3):272-80. PubMed ID: 1818798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.